Skip to main content
TipRanks
Go Ultimate75% OFF
Mission Therapeutics logo

Mission Therapeutics: Valuation, Funding & Investors

Moneta, Building 280 Babraham Research Campus Cambridge, Cambs CB22 3AT, GBhttps://www.missiontherapeutics.com/Therapeutics

Mission Therapeutics is a clinical-stage biotech company specializing in the development of first-in-class therapeutics that enhance mitophagy to promote cell and organ health. The company focuses on targeting mitochondrial dysfunction, a key factor in various diseases, including Parkinson's disease, acute kidney injury, and heart failure. Their lead candidate, MTX325, is a USP30 inhibitor designed to improve mitochondrial quality and is currently in clinical development for Parkinson's disease.

Leadership & Board

Current Number of Employees
11
Current LinkedIn Followers
9,449

Latest Estimated Valuation

Total Amount Raised
$13M
Total Funding Rounds
1
Latest Funding Amount
$13M
Latest Funding Round
Investment

Company Momentum

Positive
Articles Published on TipRanks1
LinkedIn Trend+0.16% followers
Workforce Trend+0.0% employees

Mission Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

Mission Therapeutics had 11 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

11Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Mission Therapeutics had 9,449 followers as of November 16, 2026. The number of followers increased by 15 (0.16%) week-over-week.

9,449Latest Followers Count
15(0.16%)Week-Over-Week Change
05,00010,00015,00020,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 15, 2025Investment$13.30M―

Investors

Investor NameFunding Round
SR OneInvestment
Sofinnova PartnersInvestment
Roche Venture FundInvestment
Pfizer Venture InvestmentsInvestment
IP GroupInvestment
Rosetta CapitalInvestment

Similar Companies

A snapshot of private companies similar to Mission Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis